Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease.
about
Study designs to investigate Nox1 acceleration of neoplastic progression in immortalized human epithelial cells by selection of differentiation resistant cellsBiochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular systemNADPH oxidases in lung health and diseaseExposure to heavy ion radiation induces persistent oxidative stress in mouse intestineNovel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapyTks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formationTargeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanismNADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colonNADPH oxidases: a perspective on reactive oxygen species production in tumor biologyEmerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases.NOX enzymes and pulmonary disease.Expression of NADPH oxidase homologues and accessory genes in human cancer cell lines, tumours and adjacent normal tissuesCancer stem cell theory and the warburg effect, two sides of the same coin?Downstream targets and intracellular compartmentalization in Nox signaling.Roles of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase in Angiogenesis: Isoform-Specific EffectsCombined NADPH oxidase 1 and interleukin 10 deficiency induces chronic endoplasmic reticulum stress and causes ulcerative colitis-like disease in miceP21-activated kinase in inflammatory and cardiovascular disease.Implications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel diseaseTumor necrosis factor-α-induced colitis increases NADPH oxidase 1 expression, oxidative stress, and neutrophil recruitment in the colon: preventive effect of apocynin.Protective action of NADPH oxidase inhibitors and role of NADPH oxidase in pathogenesis of colon inflammation in mice.The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balanceIntestinal NADPH oxidase 2 activity increases in a neonatal rat model of necrotizing enterocolitis.Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.Influence of NADPH oxidase on inflammatory response in primary intestinal epithelial cells in patients with ulcerative colitis.Chemistry meets biology in colitis-associated carcinogenesisLipid raft redox signaling: molecular mechanisms in health and disease.The gut microbiota engages different signaling pathways to induce Duox2 expression in the ileum and colon epithelium.NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7.Subcellular localization and function of alternatively spliced Noxo1 isoformsNox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy.Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1.NADPH oxidases: an overview from structure to innate immunity-associated pathologies.Suppressive effects of the NADPH oxidase inhibitor apocynin on intestinal tumorigenesis in obese KK-A(y) and Apc mutant Min mice.The Gastric Mucosa from Patients Infected with CagA+ or VacA+ Helicobacter pylori Has a Lower Level of Dual Oxidase-2 Expression than Uninfected or Infected with CagA-/VacA- H. pylori.Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancerNox1 is over-expressed in human colon cancers and correlates with activating mutations in K-Ras.Indole-3- carbinol enhances sorafenib cytotoxicity in hepatocellular carcinoma cells: A mechanistic studyInflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets.N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: randomized, placebo-controlled pilot study
P2860
Q26852739-5AB795BA-F0AB-4F87-B23B-175D7F8B257FQ26991619-4A3BA7A0-CFB4-424C-9203-CEB2DFA3DD7AQ27027435-FC26D6E4-D46E-4B80-9112-9412B88AC427Q28482558-723E1986-61AC-4382-B19D-E93D477B9A61Q28483560-A3A4773C-C889-4595-AEEE-4A35FC850E12Q28586447-F143DEAE-9B05-4D87-BBF6-1799DF48D85BQ28743072-22502B29-AB09-44FA-B13C-A642BFA99F6AQ33547282-B6298B9E-7B4F-4C2F-9886-6144407DC6C2Q33632660-BBF80C8A-0511-48FF-8D80-DD6DBDC94DA8Q33649841-C80C7114-C84B-4189-BB44-40ED31C719E5Q33649864-E5536708-BBBC-4678-BF44-0BDFB8EDAA23Q33745533-5FC1A4D6-AA35-4224-9665-CFE5CC90EAD1Q33755908-8BD1D283-DDAD-4304-8BFB-E23FA03C8B66Q33818148-FC89831D-3587-4953-ABB9-22B356E88E60Q33845071-252989CB-78C2-4996-9B6D-1A5B36F2CD45Q33875033-D3C01FE5-8B08-4634-B185-E38C1BB236FEQ34032604-5D29E115-3B77-4A52-BE95-54A20C897A47Q34052630-DF8A5CC9-2DBB-41F6-9634-3899F87530ACQ34207197-9A2762E7-6926-4C10-BDF5-79C14A0989F1Q34207832-3D7B8D93-AC54-49FA-8DFE-63666D305C77Q34562975-BF8CA1F1-B09E-406D-BF01-8BD98A600FF3Q34724693-9F3AA211-E15B-4FD2-A932-2150601F18CEQ34893991-AFEBCAB2-57A3-453B-ACB2-B7D8301C6B02Q35042743-07A33429-36BE-465A-BC89-DA99521079FFQ35047726-370C3445-311B-40CC-826A-00F48B763C23Q35101890-32B41F05-37A1-4F45-9984-23524DA8C7C9Q35232650-05486092-9AD7-41E3-971C-22BF48FF04E1Q35684534-1C504BD9-9443-4675-A473-B725C0E8C80FQ35785962-9C516036-5E9D-4A9B-BBB1-6364A7344B10Q35792499-4F4B081F-131A-440D-885D-EDA554F388EBQ36052377-636CDBEF-05B1-4E95-B837-526C218A603EQ36202911-26CBBD96-31C1-4F9E-89FC-9083835DF426Q36302873-B9D0CE22-0CD6-4600-A4EC-8BC44453E773Q36467448-7A10A96F-CE24-4E20-ACCC-B43D55C1BEA2Q37092643-3DF8CC00-3161-4486-BDB7-C4880EBA9345Q37158989-C94FE96F-B515-43FE-A76A-450D29115954Q37173872-4146AE84-3B71-44D5-B92D-4BD825AAB408Q37244398-EF3E22CF-8795-41A6-A858-9E65E387F715Q37258771-5B1BD7CF-FDDB-48D5-9BA2-13641012F5EAQ37261921-70C2AB37-7285-4D82-AE63-D74D8B9F5592
P2860
Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Expression of NOX1, a superoxi ...... nd inflammatory bowel disease.
@en
Expression of NOX1, a superoxi ...... nd inflammatory bowel disease.
@nl
type
label
Expression of NOX1, a superoxi ...... nd inflammatory bowel disease.
@en
Expression of NOX1, a superoxi ...... nd inflammatory bowel disease.
@nl
prefLabel
Expression of NOX1, a superoxi ...... nd inflammatory bowel disease.
@en
Expression of NOX1, a superoxi ...... nd inflammatory bowel disease.
@nl
P2093
P2860
P50
P356
P1476
Expression of NOX1, a superoxi ...... and inflammatory bowel disease
@en
P2093
P2860
P304
P356
10.1002/PATH.1824
P577
2005-10-01T00:00:00Z